Murray Passo to Child, Preschool
This is a "connection" page, showing publications Murray Passo has written about Child, Preschool.
Connection Strength
0.349
-
Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus. 2006; 15(4):198-206.
Score: 0.039
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
Score: 0.024
-
Use of methotrexate in children. Bull Rheum Dis. 1998 Aug; 47(5):1-5.
Score: 0.023
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in?Children With Polyarticular Forms of Juvenile Idiopathic?Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.023
-
Magnetic resonance imaging in juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1997 Dec; 27(3):161-8.
Score: 0.022
-
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 May; 65(5):745-52.
Score: 0.016
-
Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011 Nov; 63(11):1511-6.
Score: 0.015
-
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007 Mar; 56(3):965-71.
Score: 0.011
-
Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986 May; 31(5):492-7.
Score: 0.010
-
What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis? Clin Exp Rheumatol. 2006 May-Jun; 24(3):333-43.
Score: 0.010
-
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2005 Aug 15; 53(4):565-70.
Score: 0.010
-
Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire. J Clin Rheumatol. 2005 Aug; 11(4):194-204.
Score: 0.009
-
Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis. Arthritis Rheum. 2004 Dec 15; 51(6):899-908.
Score: 0.009
-
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005; 7(1):R30-7.
Score: 0.009
-
Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum. 2004 Oct 15; 51(5):763-73.
Score: 0.009
-
Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum. 2004 Jun 15; 51(3):365-70.
Score: 0.009
-
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004 May; 50(5):1595-603.
Score: 0.009
-
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003 Mar; 142(3):292-6.
Score: 0.008
-
Aches and limb pain. Pediatr Clin North Am. 1982 Feb; 29(1):209-19.
Score: 0.007
-
Arthritis in childhood. J Indiana State Med Assoc. 1981 Sep; 74(9):559-64.
Score: 0.007
-
Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001 Jun 01; 166(11):6899-906.
Score: 0.007
-
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. J Rheumatol. 2001 May; 28(5):1106-11.
Score: 0.007
-
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum. 1999 Oct; 42(10):2213-9.
Score: 0.006
-
Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum. 1999 Sep; 42(9):1843-53.
Score: 0.006
-
Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol. 1998 Jul; 25(7):1388-98.
Score: 0.006
-
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum. 1997 Nov; 40(11):1976-83.
Score: 0.006
-
Long term follow-up of children with mixed connective tissue disease. Lupus. 1996 Jun; 5(3):221-6.
Score: 0.005
-
Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J Rheumatol. 1996 Apr; 23(4):747-52.
Score: 0.005
-
Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol. 1994 Dec; 21(12):2353-8.
Score: 0.005
-
The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J Rheumatol. 1992 Jan; 19(1):160-3.
Score: 0.004
-
Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol. 1991 Sep; 18(9):1394-7.
Score: 0.004
-
Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr. 1990 Oct; 117(4):645-52.
Score: 0.003
-
Proliferative response of peripheral blood mononuclear cells to autologous and allogeneic muscle in patients with polymyositis/dermatomyositis. Arthritis Rheum. 1989 Apr; 32(4):446-53.
Score: 0.003
-
Chemotherapy-associated Raynaud's phenomenon in a two-year-old girl. Med Pediatr Oncol. 1985; 13(6):392-4.
Score: 0.002